L logo

Loews Corporation (L)

$109.83

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on L

Market cap

$22.45B

EPS

8.15

P/E ratio

13.5

Price to sales

1.2

Dividend yield

0.228%

Beta

0.521897

Price on L

Previous close

$110.70

Today's open

$111.46

Day's range

$109.77 - $111.46

52 week range

$95.10 - $121.01

Profile about L

CEO

Benjamin Tisch

Employees

13000

Headquarters

New York, NY

Exchange

New York Stock Exchange

Shares outstanding

204427720

Issue type

Common Stock

L industries and sectors

Finance

Insurance

News on L

LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK

NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Loews Corporation (NYSE: L) announced today the declaration of the Company's quarterly dividend of $0.0625 per share of Common Stock, payable September 1, 2026 to shareholders of record as of the close of business on August 19, 2026. Loews Corporation is a diversified company with businesses in the insurance, energy, hospitality, and packaging industries.

news source

PRNewsWire • Aug 4, 2026

news preview

Hotels and pipelines drive Loews profits higher as insurance underwriting softens

Loews Corp (NYSE:L), the New York-listed conglomerate with interests in insurance, pipelines, hotels and packaging, reported second-quarter net income of $444 million as its smaller businesses picked up the slack from a weakening insurance market. That compares with $391 million a year earlier, with earnings per share rising to $2.16 from $1.87.

news source

Proactive Investors • Aug 3, 2026

news preview

LOEWS CORPORATION REPORTS NET INCOME OF $444 MILLION FOR THE SECOND QUARTER OF 2026

NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Loews Corporation (NYSE: L) today released its second quarter 2026 financial results. Second Quarter 2026 highlights: Loews Corporation reported net income of $444 million, or $2.16 per share, in the second quarter of 2026, compared to $391 million, or $1.87 per share, in the second quarter of 2025.

news source

PRNewsWire • Aug 3, 2026

news preview

Loews Corporation to Release Second Quarter 2026 Results on August 3, 2026

NEW YORK, July 14, 2026 /PRNewswire/ -- Loews Corporation (NYSE: L) will report second quarter 2026 financial results on Monday, August 3, 2026. On that date the Company will also post earnings remarks on its website.

news source

PRNewsWire • Jul 14, 2026

news preview

EQB builds leadership team for its next chapter welcoming senior PC Financial executives and expanding key mandates

As EQB prepares to close its Acquisition of PC Financial on July 1, 2026, the company announces a strengthened leadership team drawing on talent from both organizations, positioning EQB for a differentiated phase of growth Key appointments include: Ian Hanning from PC Financial to SVP, Credit Cards and Loyalty Mark Snyder from PC Financial to SVP, Credit Risk and Data Analytics Michaela Garfield from PC Financial to SVP, Customer Growth, Experience and Strategy, Personal Banking Puneesh Arora from PC Financial to EVP and Chief Risk Officer, with current EVP and Chief Risk Officer Marlene Lenarduzzi to act as Special Advisor until Jan 1, 2027 Daniel Rethazy's mandate expanding as EVP Personal Banking to include PC Financial businesses Anilisa Sainani's mandate as CFO expanding to include Strategy and Corporate Development Gavin Stanley's mandate as CHRO expanding to include Brand and Marketing Caleb Rubin appointed as Chief Brand Officer Dan Broten appointed Chief Digital Officer David Wilkes appointed SVP, Deposits, Payments and Small Business Banking Dipti Patel elevated to Chief Credit Officer and Deputy CRO Julia Davidson appointed Chief Operating Officer, Commercial Banking Lemar Persaud appointed SVP, Investor Relations and Enterprise Performance Management TORONTO, June 16, 2026 /PRNewswire/ - EQB Inc. (TSX: EQB) today announced a comprehensive set of executive appointments and elevations as the company prepares to close its acquisition ("the Acquisition") of PC Financial1 from Loblaw Companies Limited ("Loblaw") (TSX: L) on July 1, 2026. This strengthened leadership team brings multiple senior PC Financial leaders onto the EQB Executive Leadership Team (ELT), alongside a series of expanded mandates for existing leaders, building the organizational capabilities required to serve millions of Canadians across a broader and more complex set of financial products and services.

news source

PRNewsWire • Jun 16, 2026

news preview

Real Canadian Superstore at Buffalo Run Set to Open This Fall

Transformative partnership between Tsuut'ina Nation, Taza Development Corp. and Real Canadian Superstore advances as opening preparations get underway Transformative partnership between Tsuut'ina Nation, Taza Development Corp. and Real Canadian Superstore advances as opening preparations get underway

news source

GlobeNewsWire • Jun 12, 2026

news preview

Shoppers Foundation for Women's Health™ announces funding commitments to advance menstrual equity in Canada

TORONTO, May 26, 2026 (GLOBE NEWSWIRE) -- Ahead of Menstrual Health Day on May 28, Shoppers Foundation for Women's Health™ is proud to announce $300,000 in funding commitments over two years to support organizations advancing menstrual equity in Canada.

news source

GlobeNewsWire • May 26, 2026

news preview

Loblaw April Food Inflation Report

TORONTO, May 26, 2026 (GLOBE NEWSWIRE) -- In the latest edition of its Food Inflation Report, Loblaw is pleased to provide context around what's impacting food prices – now and into the future. This report follows Statistics Canada's release of data for the month of April.

news source

GlobeNewsWire • May 26, 2026

news preview

Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the marketing authorization of Trodelvy® (sacituzumab govitecan-hziy) as a monotherapy for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy for met.

news source

Business Wire • May 22, 2026

news preview

Want to be a real Insider this summer? President's Choice unveils its annual PC® Summer Insiders Report™, featuring bold taste discoveries and endless summer inspiration you won't want to miss

BRAMPTON, Ontario, May 19, 2026 (GLOBE NEWSWIRE) -- Being an Insider is all about the thrill of discovery, that can't-wait-to-see-what's-next energy. Here at President's Choice, we're always pushing new taste possibilities.

news source

GlobeNewsWire • May 19, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Loews Corporation

Open an M1 investment account to buy and sell Loews Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in L on M1